Catheter Precision Soars 115.04% on VIVO Purchase Order

On June 11, 2025, Catheter Precision's stock surged by 115.04% in pre-market trading, marking a significant rise that has captured the attention of investors and analysts alike.

Catheter Precision, Inc. recently secured a VIVO purchase order from Sahlgrenska University Hospital, a notable achievement that has contributed to the company's recent stock performance. This order underscores the growing demand for Catheter Precision's innovative medical devices and highlights the company's expanding presence in the European market.

The positive market sentiment surrounding Catheter Precision is further bolstered by the company's after-hours performance, which saw a 76.46% rise. This remarkable after-hours performance is a testament to the market's confidence in the company's future prospects and its ability to deliver on its promises.

Overall, the recent developments at Catheter Precision, including the VIVO purchase order and strong after-hours performance, have positioned the company as a promising player in the medical device industry. Investors are closely monitoring the company's progress, anticipating further growth and innovation in the coming months.